FABLYSE

DEAD

Serial Number

88194104

Owner

Endo Pharmaceuticals Inc.

Attorney

Camille M. Miller

Filing Date

Nov 14, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FABLYSE Trademark

Serial Number: 88194104 • Registration: 5842986

FABLYSE is a trademark filed by Endo Pharmaceuticals Inc. on November 14, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Endo Pharmaceuticals Inc.

Malvern, PA 19355

Entity Type: 03

ENDO OPERATIONS LIMITED (142 trademarks)

FIRST FLOOR, MINERVA HOUSE
BALLSBRIDGE, DUBLIN 4 , IE

Entity Type: 77

Legal Representation

Attorney of Record

Camille M. Miller

6,745 trademarks filed View all →

Correspondence Address

CAMILLE M. MILLER COZEN O'CONNOR

1650 MARKET STREET

SUITE 2800

PHILADELPHIA, PA 19103

UNITED STATES

Trademark Details

Filing Date

November 14, 2018

Registration Date

August 27, 2019

Published for Opposition

June 11, 2019

Cancellation Date

March 13, 2026

Goods & Services

Drug substances, namely, enzymes; pharmaceutical preparations for the treatment of cellulite

Filing History

CANCELLED SEC. 8 (6-YR)

Mar 13, 2026 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 27, 2024 REM1

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jun 28, 2024 ASCK

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 1, 2024 ASGN

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Dec 22, 2021 ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Jun 3, 2020 ASCK

REGISTERED-PRINCIPAL REGISTER

Aug 27, 2019 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 11, 2019 NPUB

PUBLISHED FOR OPPOSITION

Jun 11, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 22, 2019 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 6, 2019 CNSA

EXAMINER'S AMENDMENT ENTERED

Apr 19, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 19, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Apr 19, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Apr 19, 2019 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 19, 2019 GNRN

NON-FINAL ACTION E-MAILED

Apr 19, 2019 GNRT

NON-FINAL ACTION WRITTEN

Apr 19, 2019 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 2, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 2, 2019 CRFA

ASSIGNED TO LIE

Mar 31, 2019 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Mar 26, 2019 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 22, 2019 GNS3

LETTER OF SUSPENSION E-MAILED

Feb 22, 2019 GNSL

SUSPENSION LETTER WRITTEN

Feb 22, 2019 CNSL

ASSIGNED TO EXAMINER

Feb 19, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 2, 2018 NWOS

NEW APPLICATION ENTERED

Nov 17, 2018 NWAP

Related Trademarks

More from this Owner

TRURFID

TRUDELIVERY

ENDO GENERICS PAR PHARMACEUTICAL

ENDO INJECTABLE SOLUTIONS

More in Same Class